Ionis Pharmaceuticals (IONS) Change in Account Payables (2013 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Change in Account Payables of $21.7 million for Q2 2026, up 283.07% year-over-year from $5.7 million in Q2 2025, and up 800.42% quarter-over-quarter from -$3.1 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Change in Account Payables (2013 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Change in Account Payables history runs 14 years deep, the most recent figure standing at $21.7 million for Q2 2026.
- In Q2 2026, Change in Account Payables rose 283.07% year-over-year to $21.7 million; the TTM figure through Jun 2026 stood at $23.5 million (up 84.64% YoY), while the FY2025 annual figure was -$15.4 million, down 196.06% from the prior year.
- Change in Account Payables for Q2 2026 stood at $21.7 million, up from -$3.1 million in the prior quarter.
- The five-year high for Change in Account Payables was $35.2 million in Q4 2024, with the low at -$26.0 million in Q1 2025.
- The 5-year median for Change in Account Payables is -$1.0 million (2024), against an average of $1.6 million.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables soared 556.04% in 2023, then sank 44113.56% in 2025.
- Ionis Pharmaceuticals' Change in Account Payables stood at -$4.5 million in 2022, then jumped by 556.04% to $20.6 million in 2023, then jumped by 71.06% to $35.2 million in 2024, then plunged by 60.93% to $13.8 million in 2025, then jumped by 57.59% to $21.7 million in 2026.
- Business Quant data shows IONS's Change in Account Payables at $21.7 million in Q2 2026, -$3.1 million in Q1 2026, and $13.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 21.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.68 Mn |
| Jun 30, 2026 | 21.68 Mn |
| Mar 31, 2026 | -3.10 Mn |
| Mar 31, 2026 | -3.10 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Sep 30, 2025 | -8.81 Mn |
| Sep 30, 2025 | -8.81 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | -25.97 Mn |
| Mar 31, 2025 | -25.97 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -17.12 Mn |
| Jun 30, 2024 | -17.12 Mn |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |